山奈酚通过维持神经钙调蛋白抑制剂存在下的CD4+FoxP3+调节性T细胞促进移植耐受
Calcineurin inhibitor cyclosporine is widely used as an immunosuppressant in clinic. However, mounting evidence has shown that cyclosporine hinders tolerance induction by dampening Tregs. Therefore, it is of paramount importance to overcome this pitfall. Kaempferol was reported to inhibit DC function. Here, we found that kaempferol delayed islet allograft rejection. Combination of kaempferol and low-dose, but not high-dose, of cyclosporine induced allograft tolerance in majority of recipient mice. Although kaempferol plus either dose of cyclosporine largely abrogated proliferation of graft-infiltrating T cells and their CTL activity, both proliferation and CTL activity in mice treated with kaempferol plus low-dose, but not high-dose, cyclosporine reemerged rapidly upon treatment withdrawal. Kaempferol increased CD4+FoxP3+ Tregs both in transplanted mice and in vitro, likely by suppressing DC maturation and their IL-6 expression. Reduction in Tregs by low dose of cyclosporine was reversed by kaempferol. Kaempferol-induced Tregs exhibited both allospecific and non-allospecific suppression. Administering IL-6 abrogated allograft tolerance induced by kaempferol and cyclosporine via diminishing CD4+FoxP3+ Tregs. Thus, for the first time, we demonstrated that kaempferol promotes transplant tolerance in the presence of low dose of cyclosporine, which allows for sufficient Treg generation while minimizing side effects, resulting in much-needed synergy between kaempferol and cyclosporine. Using a murine model of islet transplantation, the authors demonstrate that kaempferol induces allograft tolerance in the presence of cyclosporine by sustaining CD4+FoxP3+ regulatory T cells via suppression of dendritic cell maturation and its IL-6 expression. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.
上一篇: 自噬通过缓解血气屏障损伤避免缺血再灌注损伤诱导的肺损伤
下一篇: 膜联蛋白A4与癌症
来源: Scopus
- 您可能感兴趣的文章
-